Gastrointestinal Cancers

During October, the FDA approved drugs to treat diseases including breast cancer, lung cancer, leukemia and gastric cancer.

In the first 15 patients, radiofrequency ablation was shown to reduce pain scores in most patients with pancreatic cancer.

Stivarga improved survival and delayed disease progression in patients with refractory advanced gastric and esophagogastric junction cancer.

The FDA has approved Vyloy for patients with HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma with CLDN18.2-positive tumors.

Patients with gallbladder cancer and cholangiocarcinoma may benefit from receiving Avastin plus Tarceva versus active surveillance.

For patients with adenocarcinoma of the esophagus and esophagogastric junction, chemoradiotherapy and chemotherapy improved survival versus surgery alone.

Several colleagues, patients and caregivers nominated Jill May, B.S.N., RN, OCN, for the 2024 Extraordinary Healer Award for her dedicating to caring for those with gastrointestinal cancers.

From good news for a rock star to the deaths of stage and screen stars, here’s what’s happening in the cancer space this week.

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal stromal tumors.

I invited my family to gather with me and celebrate four years of being cancer-free.

From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.

In patients with unresectable liver cancer, treatment with Imjudo plus Imfinzi showed better survival outcomes compared with Nexavar.

Before receiving my colorectal cancer diagnosis, I had experienced cancer. However, my depression felt different during treatment.

Steatotic liver disease was associated with better liver function, lower recurrence rates, and improved overall survival in patients with liver cancer who received radiofrequency ablation.

In patients with BRAF V600E-mutant metastatic colorectal cancer, a combination of Braftovi, Erbitux and chemotherapy showed promising antitumor activity.

Patients with metastatic disease whose cancers were tested and treated for specific mutations tended to have better outcomes than those given the standard of care.

Adding Zynyz to carboplatin and paclitaxel prolonged survival without progression in chemotherapy-naive recurrent or metastatic squamous cell carcinoma of the anal canal.

Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial chemoembolization.

From Princess Kate entering ‘a new phase of recovery’ to a Rock and Roll Hall of Famer’s blood cancer announcement, here’s what’s happening in the cancer space this week.

Patients with oligometastatic pancreatic cancer showed better progression-free survival after receiving metastasis-directed therapy with chemotherapy.

Researchers are enrolling patients in a trial of ELI-00 7P — a vaccine to treat KRAS-mutant cancer.

From pro wrestling legend Sid Vicious dying of cancer to Nicole Eggert’s breast cancer update, here’s what’s happening in the oncology space this week.

Chemotherapy and radiotherapy may be efficacious enough for certain patients with advanced rectal cancer to avoid surgery, research showed.

Patients with cancer who did 20-minute guided mindful breathing tended to have a more significant decrease in cancer-related pain and anxiety.

Helping others through their cancer experience helped with my own feelings of survivor's guilt.